CD40LG and schizophrenia: However, it was readily possible to “construct” a 22.5% subgroup of patients (F2 diagnoses) and a 19.6% subgroup of patients (F3 diagnoses) for which highly significant correlations showed up between IgM levels on one hand, and the global schizophrenia and depression scores on the other.